Cargando…

Myricetin Suppresses Ovarian Cancer In Vitro by Activating the p38/Sapla Signaling Pathway and Suppressing Intracellular Oxidative Stress

Ovarian cancer is a common malignancy with a mortality and effective, efficient treatments are urgently needed. Myricetin (Myr) is a flavonoid with antioxidant and anticancer properties. Here, we assessed Myr’s toxicity on the non-tumor cell line, IOSE-80 and the mechanism by which it suppresses pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Qi, Tan, Qi, Ma, Yangfei, Gu, Zehui, Chen, Suxian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130763/
https://www.ncbi.nlm.nih.gov/pubmed/35646711
http://dx.doi.org/10.3389/fonc.2022.903394
_version_ 1784713042046484480
author Li, Qi
Tan, Qi
Ma, Yangfei
Gu, Zehui
Chen, Suxian
author_facet Li, Qi
Tan, Qi
Ma, Yangfei
Gu, Zehui
Chen, Suxian
author_sort Li, Qi
collection PubMed
description Ovarian cancer is a common malignancy with a mortality and effective, efficient treatments are urgently needed. Myricetin (Myr) is a flavonoid with antioxidant and anticancer properties. Here, we assessed Myr’s toxicity on the non-tumor cell line, IOSE-80 and the mechanism by which it suppresses proliferation, migration, and invasion of ovarian cancer SKOV3 cells. The effects of Myr on SKOV3 cells were assessed using CCK-8, oxidative stress, wound healing, Transwell, Hoechst 33258 staining, and western blot assays. Our data show that although Myr was not toxic against IOSE-80 cells for a range of concentrations 0-40μM, it suppressed SKOV3 cell proliferation, migration, and invasion and enhanced apoptosis. Mechanistically, it activated the p38/Sapla signaling pathway, thereby inhibiting oxidative stress and reducing the level of ROS in tumor cells. Our data show that Myr suppresses ovarian cancer cells in vitro and suggests Myr as a candidate agent against ovarian cancer.
format Online
Article
Text
id pubmed-9130763
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-91307632022-05-26 Myricetin Suppresses Ovarian Cancer In Vitro by Activating the p38/Sapla Signaling Pathway and Suppressing Intracellular Oxidative Stress Li, Qi Tan, Qi Ma, Yangfei Gu, Zehui Chen, Suxian Front Oncol Oncology Ovarian cancer is a common malignancy with a mortality and effective, efficient treatments are urgently needed. Myricetin (Myr) is a flavonoid with antioxidant and anticancer properties. Here, we assessed Myr’s toxicity on the non-tumor cell line, IOSE-80 and the mechanism by which it suppresses proliferation, migration, and invasion of ovarian cancer SKOV3 cells. The effects of Myr on SKOV3 cells were assessed using CCK-8, oxidative stress, wound healing, Transwell, Hoechst 33258 staining, and western blot assays. Our data show that although Myr was not toxic against IOSE-80 cells for a range of concentrations 0-40μM, it suppressed SKOV3 cell proliferation, migration, and invasion and enhanced apoptosis. Mechanistically, it activated the p38/Sapla signaling pathway, thereby inhibiting oxidative stress and reducing the level of ROS in tumor cells. Our data show that Myr suppresses ovarian cancer cells in vitro and suggests Myr as a candidate agent against ovarian cancer. Frontiers Media S.A. 2022-05-11 /pmc/articles/PMC9130763/ /pubmed/35646711 http://dx.doi.org/10.3389/fonc.2022.903394 Text en Copyright © 2022 Li, Tan, Ma, Gu and Chen https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Li, Qi
Tan, Qi
Ma, Yangfei
Gu, Zehui
Chen, Suxian
Myricetin Suppresses Ovarian Cancer In Vitro by Activating the p38/Sapla Signaling Pathway and Suppressing Intracellular Oxidative Stress
title Myricetin Suppresses Ovarian Cancer In Vitro by Activating the p38/Sapla Signaling Pathway and Suppressing Intracellular Oxidative Stress
title_full Myricetin Suppresses Ovarian Cancer In Vitro by Activating the p38/Sapla Signaling Pathway and Suppressing Intracellular Oxidative Stress
title_fullStr Myricetin Suppresses Ovarian Cancer In Vitro by Activating the p38/Sapla Signaling Pathway and Suppressing Intracellular Oxidative Stress
title_full_unstemmed Myricetin Suppresses Ovarian Cancer In Vitro by Activating the p38/Sapla Signaling Pathway and Suppressing Intracellular Oxidative Stress
title_short Myricetin Suppresses Ovarian Cancer In Vitro by Activating the p38/Sapla Signaling Pathway and Suppressing Intracellular Oxidative Stress
title_sort myricetin suppresses ovarian cancer in vitro by activating the p38/sapla signaling pathway and suppressing intracellular oxidative stress
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130763/
https://www.ncbi.nlm.nih.gov/pubmed/35646711
http://dx.doi.org/10.3389/fonc.2022.903394
work_keys_str_mv AT liqi myricetinsuppressesovariancancerinvitrobyactivatingthep38saplasignalingpathwayandsuppressingintracellularoxidativestress
AT tanqi myricetinsuppressesovariancancerinvitrobyactivatingthep38saplasignalingpathwayandsuppressingintracellularoxidativestress
AT mayangfei myricetinsuppressesovariancancerinvitrobyactivatingthep38saplasignalingpathwayandsuppressingintracellularoxidativestress
AT guzehui myricetinsuppressesovariancancerinvitrobyactivatingthep38saplasignalingpathwayandsuppressingintracellularoxidativestress
AT chensuxian myricetinsuppressesovariancancerinvitrobyactivatingthep38saplasignalingpathwayandsuppressingintracellularoxidativestress